MICHEL, ANNE,DOWNEY, PATRICK,MONTEL, FLORIAN,SCHELLER, DIETER,CHRISTOPHE, BERNARD
申请号：
CA2869216
公开号：
CA2869216A1
申请日:
2013.04.19
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The invention pertains to a method of treating Parkinson's disease (PD) in a mammal, comprising administering a first pharmaceutical agent and a second pharmaceutical agent, wherein the first pharmaceutical agent is an antagonist of the adenosine receptor 2 (A2A) and the second pharmaceutical agent is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subtype NR2B.
